Seattle, WA, United States of America

John D Hoekman

This inventor holds 21 USPTO granted patents and 18 published patent applications, plus 6 CIPO patents and 10 EPO patents. Top assignees: Impel Neuropharma, Inc., Impel Pharmaceuticals Inc., University of Washington. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John D Hoekman. Retrieved from https://idiyas.com/inventor/john-d-hoekman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 95.2

 

 

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: John D Hoekman - Innovator from Seattle, WA

Introduction: John D Hoekman is a renowned inventor based in Seattle, WA, known for his groundbreaking contributions to various industries through his innovative creations.

Latest Patents: John D Hoekman holds several patents in the fields of technology, healthcare, and sustainability, showcasing his diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, John D Hoekman has worked with leading companies to develop cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, John D Hoekman has collaborated with top researchers, engineers, and scientists to bring his ideas to life, resulting in successful products that have had a significant impact on society.

Conclusion: John D Hoekman's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…